Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We examined prevalence of sarcopenia in Korean patients with type 2 diabetes and compared body compositional parameters between subjects with and without type 2 diabetes. RESEARCH DESIGN AND METHODS: The Korean Sarcopenic Obesity Study (KSOS) included 810 subjects (414 patients with diabetes and 396 control subjects) who were examined using dual-energy X-ray absorptiometry. Prevalence of sarcopenia was defined using the skeletal muscle index (SMI). RESULTS: Prevalence in patients with diabetes and in the control group was 15.7 and 6.9%, respectively. In both men and women, SMI values were significantly decreased in patients with diabetes compared with subjects without diabetes. Furthermore, multiple logistic regression analysis showed that type 2 diabetes was independently associated with sarcopenia. CONCLUSIONS: Type 2 diabetes was associated with increased risk of sarcopenia. These characteristics may contribute to physical disability and metabolic disorders in older adults with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We also previously reported that patients with type 2 diabetes mellitus had higher BMI and a low appendicular skeletal mass and skeletal muscle index [132].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [132]
In the citing paper
“Furthermore, the characteristic may attribute to physical disability and metabolic syndromes, which has been clarified in another Korean study (57).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [57]
In the citing paper
“indicating that diabetes is associated with increased risk of SO.”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [57]
In the citing paper
“a study has found that in the case of similar BMI, diabetics have decreased lean body mass and increased body fat mass compared with non-diabetics (57)”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“ASM/height 2 and SMI were performed as previously described (7-10).”
MethodJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“ASM/height 2 and SMI were performed as previously described (7-10).”
MethodSkeletal muscle mass and distribution in 468 men and women aged 18–88 yr
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.81 · Cited by 3,087 · cited 1×
“Our findings are in agreement with several previous studies demonstrating that men lose greater skeletal muscle mass with aging, even though they have greater skeletal muscle mass than women (11,12) and that women with diabetes are at particularly high risk for loss of skeletal muscle mass (4).”
ResultDiabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997 · cited 1×
“In addition, Asian populations are more prone to abdominal obesity and low skeletal muscle mass (sarcopenia) with increased insulin resistance compared with their Western counterparts (2).”
Epidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580 · cited 1×
“P eople in Asia tend to develop type 2 diabetes with less degree of obesity (1).”
BackgroundAppendicular skeletal muscle mass: effects of age, gender, and ethnicity
Gallagher, D., Visser, M., De Meersman, R. E., Sepúlveda, D., Baumgartner, R. N., Pierson, R. N., Harris, T., & Heymsfield, S. B. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.229 · Cited by 966 · cited 1×
“Our findings are in agreement with several previous studies demonstrating that men lose greater skeletal muscle mass with aging, even though they have greater skeletal muscle mass than women (11,12) and that women with diabetes are at particularly high risk for loss of skeletal muscle mass (4).”
ResultAppendicular skeletal muscle mass: measurement by dual-photon absorptiometry
Heymsfield, S., Smith, R., Aulet, M., Bensen, B., Lichtman, S., Wang, J., & Pierson, R. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.2.214 · Cited by 820 · cited 1×
“ASM/height 2 and SMI were performed as previously described (7-10).”
MethodExcessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0264 · Cited by 778 · cited 2×
“Type 2 diabetes is associated with lower skeletal muscle strength and quality as well as excessive loss of skeletal muscle mass in the Health, Aging, and Body Composition (Health ABC) study (3,4).”
BackgroundResultDecreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., & Newman, A. B. (2006) · Diabetes · doi:10.2337/db05-1183 · Cited by 751
Salti, I., Bénard, E., Detournay, B., Bianchi-Biscay, M., Le Brigand, C., Voinet, C., Jabbar, A., & on behalf of the EPIDIAR Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2306 · Cited by 742 · cited 1×
“Medical histories and lifestyle information were collected by personal interview using a detailed questionnaire (6).”
Cited by
Items 201–300 of 588
The AMPK-related kinase SNARK regulates muscle mass and myocyte survival
Lessard, S. J., Rivas, D. A., So, K., Koh, H., Queiroz, A. L., Hirshman, M. F., Fielding, R. A., & Goodyear, L. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79197 · Cited by 46
Bouchi, R., Nakano, Y., Ohara, N., Takeuchi, T., Murakami, M., Asakawa, M., Sasahara, Y., Numasawa, M., Minami, I., Izumiyama, H., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0384-7 · Cited by 36
Low relative muscle mass and left ventricular diastolic dysfunction in middle-aged adults
Ko, B., Chang, Y., Kang, J., Kim, J., Jung, H. S., Yun, K. E., Kim, C., Shin, H. C., & Ryu, S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.089 · Cited by 33
Komorita, Y., Iwase, M., Fujii, H., Ide, H., Ohkuma, T., Jodai, T., Sumi, A., Yoshinari, M., Nakamura, U., & Kitazono, T. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.021 · Cited by 34
Tan, X. W., Titova, O. E., Lindberg, E., Elmståhl, S., Lind, L., Schiöth, H. B., & Benedict, C. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7668 · Cited by 35
Okamura, T., Hashimoto, Y., Miki, A., Kaji, A., Sakai, R., Iwai, K., Osaka, T., Kitagawa, N., Ushigome, E., Hamaguchi, M., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0024 · Cited by 35
Wood, N., Straw, S., Scalabrin, M., Roberts, L. D., Witte, K. K., & Bowen, T. S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13121 · Cited by 33
“muscle atrophy compared with controls with a prevalence of approximately 15%, which is linked to a poorer prognosis.(50)”
BackgroundOtsuka, H., Yokomizo, H., Nakamura, S., Izumi, Y., Takahashi, M., Obara, S., Nakao, M., Ikeda, Y., Sato, N., Sakamoto, R., et al. (2022) · Biochemical Journal · doi:10.1042/bcj20210700 · Cited by 38
Mu, Z., Fu, J., Sun, L., Chan, P., & Xiu, S. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02622-y · Cited by 36
Sarcopenia increases the risk for mortality in patients who undergo amputation for diabetic foot
Kim, Y. K., Lee, H. S., Ryu, J. J., Lee, H. I., & Seo, S. G. (2018) · Journal of Foot and Ankle Research · doi:10.1186/s13047-018-0274-1 · Cited by 39
“The prevalence of sarcopenia is as high as 15% in patients with type 2 diabetes [19].”
BackgroundPark, J. I., Bae, E., Kim, Y.-L., Kang, S., Yang, C. W., Kim, N., Lee, J. P., Kim, D. K., Joo, K. W., Kim, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136085 · Cited by 30
Self-citationKim, T. N., Lee, E. J., Hong, J. W., Kim, J. M., Won, J. C., Kim, M.-K., Noh, J. H., Ko, K. S., Rhee, B. D., & Kim, D. (2016) · Medicine · doi:10.1097/md.0000000000002500 · Cited by 33
Self-citationOkamura, T., Hashimoto, Y., Miki, A., Kaji, A., Sakai, R., Iwai, K., Osaka, T., Ushigome, E., Hamaguchi, M., Yamazaki, M., et al. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-85 · Cited by 35
Myopathy Associated With Statins and SGLT2 – A Review of Literature
Gupta, R., Alcantara, R., Popli, T., Mahajan, S., Tariq, U., Dusaj, R., & Malik, A. H. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100765 · Cited by 37
Mangou, A., Grammatikopoulou, M. G., Mirkopoulou, D., Sailer, N., Kotzamanidis, C., & Tsigga, M. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.10.003 · Cited by 31
Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
Dibai, D. B., Mendes, R. G., Arakelian, V. M., Caruso, F., Cabiddu, R., Júnior, J. C. B., Arena, R. A., & Borghi‐Silva, A. (2016) · Sports Medicine - Open · doi:10.1186/s40798-016-0052-1 · Cited by 41
Caldiroli, L., Armelloni, S., Eskander, A., Messa, P., Rizzo, V., Margiotta, E., Cesari, M., & Vettoretti, S. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111266 · Cited by 34
Mediterranean Diet attenuates risk of frailty and sarcopenia: New insights and future directions
McClure, R., & Villani, A. M. (2017) · JCSM Clinical Reports · doi:10.17987/jcsm-cr.v2i2.45 · Cited by 33
Fanelli, S. M., Kelly, O. J., Krok-Schoen, J. L., & Taylor, C. A. (2021) · Nutrients · doi:10.3390/nu13082582 · Cited by 29
“Previous studies have identified associations between sarcopenia and diabetes [5,48,49].”
BackgroundSarcopenia in diabetic nephropathy: a cross-sectional study
Çeliker, M., Selçuk, M. Y., & Olt, S. (2018) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2018-0003 · Cited by 41
The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients
Park, K., Ahn, C. W., Kim, Y.-S., & Nam, J. S. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104108 · Cited by 32
A bibliometric analysis of sarcopenia: top 100 articles
Suzan, V., & Suzan, A. A. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00395-y · Cited by 32
Yang, S., Yang, G., Wu, H., Kang, L., Xiang, J., Zheng, P., Qiu, S., Liang, Z., Lü, Y., & Jia, L. (2021) · Diabetologia · doi:10.1007/s00125-021-05616-y · Cited by 31
Self-citationShishikura, K., Tanimoto, K., Sakai, S., Tanimoto, Y., Terasaki, J., & Hanafusa, T. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0375 · Cited by 30
Free-amino acid metabolic profiling of visceral adipose tissue from obese subjects
Piro, M. C., Tesauro, M., Lena, A. M., Gentileschi, P., Sica, G. S., Rodia, G., Annicchiarico‐Petruzzelli, M., Rovella, V., Cardillo, C., Melino, G., et al. (2020) · Amino Acids · doi:10.1007/s00726-020-02877-6 · Cited by 30
Sarcopenia in chronic kidney disease: from bench to bedside
Kim, D. W., & Song, S. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.338 · Cited by 39
Song, E., Hwang, S. Y., Park, M., Jang, A., Kim, K. J., Yu, J. H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155678 · Cited by 31
Self-citationSerum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes
de Medeiros, M. C. W. C., Rocha, N. D. A., Bandeira, E., Dantas, I., Chaves, C., Oliveira, M., & Bandeira, F. A. F. (2020) · International Journal of Nephrology · doi:10.1155/2020/4596920 · Cited by 28
Choe, E. Y., Lee, Y., Choi, Y. J., Huh, B. W., Lee, B., Kim, S., Kang, E. S., Cha, B., Lee, E. J., Huh, K. B., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14011 · Cited by 28
Self-citationKang, M. K., Park, J. G., Lee, H. J., & Kim, M. C. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14607 · Cited by 28
Yuenyongchaiwat, K., Jongritthiporn, S., Somsamarn, K., Sukkho, O., Pairojkittrakul, S., & Traitanon, O. (2021) · PeerJ · doi:10.7717/peerj.11695 · Cited by 29
“Association of DM and sarcopenia has been reported in several studies (Kim et al., 2010; Park et al., 2006).”
Chung, S., Hyun, M. H., Lee, E., & Seo, H. S. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3548-0 · Cited by 26
Maliszewska, K., Adamska-Patruno, E., Gościk, J., Lipińska, D., Citko, A., Krahel, A., Miniewska, K., Fiedorczuk, J., Moroz, M., Górska, M., et al. (2019) · Nutrients · doi:10.3390/nu11040834 · Cited by 31
ナトリウム・グルコース共輸送体2(SGLT2)阻害薬カナグリフロジンは非糖尿病マウスの遅筋および速筋に異なる影響を及ぼす
Otsuka, H. (2023) · Institutional Repositories DataBase (IRDB) · Cited by 27
Kim, J. A., Hwang, S. Y., Chung, H. S., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Baik, S. H., & Yoo, H. J. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0036 · Cited by 29
Self-citationOkamura, T., Hashimoto, Y., Osaka, T., Fukuda, T., Hamaguchi, M., & Fukui, M. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-114 · Cited by 29
Association of sarcopenia with a higher risk of infection in patients with type 2 diabetes
Zhang, Y., Weng, S., Huang, L., Shen, X., Zhao, F., & Yan, S. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3478 · Cited by 34
Remelli, F., Maietti, E., Abete, P., Bellelli, G., Bo, M., Cherubini, A., Corica, F., Bari, M. D., Maggio, M. G., Rizzo, M. R., et al. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01949-1 · Cited by 28
Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia
Kingsley, J., Torimoto, K., Hashimoto, T., & Eguchi, S. (2021) · Clinical Science · doi:10.1042/cs20210719 · Cited by 29
Alabadí, B., Civera, M., la Rosa, A. D., Martínez‐Hervás, S., Gómez‐Cabrera, M. C., & Real, J. T. (2023) · Nutrients · doi:10.3390/nu15143167 · Cited by 37
“Even though there are not many longitudinal studies designed exclusively for the assessment of changes in the body composition of diabetic older adults compared to non-diabetics, in 2009, it was evidenced that in a cohort of 2675 subjects followed up for 6 years, that T2D was associated with a loss of muscle mass [25].”
BackgroundAmino acids and wound healing in people with limb-threatening diabetic foot ulcers
Hung, S., Tsai, J.-S., Yeh, J., Chen, K., Lin, C., Yang, H., Lin, C.-W., Chen, H., Huang, C., & Huang, Y. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.06.008 · Cited by 26
Chen, Y., Cai, Y.-X., Kang, X., Zhou, Z.-H., Qi, X., Ying, C., Zhang, Y., & Tao, J. (2020) · PeerJ · doi:10.7717/peerj.8793 · Cited by 28
“The risk of sarcopenia is reported to be high among patients with diabetes (Kim et al., 2010).”
BackgroundRasaei, N., Kashavarz, S. A., Yekaninejad, M. S., & Mirzaei, K. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.06.023 · Cited by 24
Lin, C., Ou, H., Hsu, H., Cheng, K., Hsieh, T.-J., Yeh, C.-H., Su, F., & Kuo, L. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02826-w · Cited by 30
Partially Hydrolyzed Guar Gum Suppresses the Development of Sarcopenic Obesity
Okamura, T., Hamaguchi, M., Mori, J., Yamaguchi, M., Mizushima, K., Abe, A., Ozeki, M., Sasano, R., Naito, Y., & Fukui, M. (2022) · Nutrients · doi:10.3390/nu14061157 · Cited by 29
“, sarcopenia and sarcopenic obesity, is strongly correlated with dietary patterns and metabolic abnormalities [2,3].”
BackgroundNishimura, A., Harashima, S., Hosoda, K., Arai, H., & Inagaki, N. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819833304 · Cited by 30
Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function
Hodson, A. E., Tippetts, T. S., & Bikman, B. T. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0316-y · Cited by 29
“Multiples lines of evidence reveal its hand in diseases stemming from cognitive [31], reproductive [32], musculoskeletal [33], and cardiovascular disorders [34].”
BackgroundZuo, X., Yao, R., Zhao, L., Zhang, Y., Lu, B., & Pang, Z. (2022) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000027 · Cited by 25
“Sarcopenia is a chronic complication of T2DM in elderly persons([13]).”
BackgroundChen, W.-M., Chen, M., Shia, B.-C., & Wu, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154424 · Cited by 29
Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease
Ida, S., Kojima, Y., Hamaoka, S., Urawa, N., Araki, J., Kaneko, R., & Murata, K. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14449 · Cited by 22
Akagawa, M., Miyakoshi, N., Kasukawa, Y., Ono, Y., Yuasa, Y., Nagahata, I., Sato, C., Tsuchie, H., Nagasawa, H., Hongo, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204857 · Cited by 23
Sidhu, S. S., Saggar, K., Goyal, O., Varshney, T., Kishore, H., Bansal, N., & Sidhu, S. S. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001761 · Cited by 22
Mo, Y., Yang, C., Su, Y.-D., Dong, X., Deng, W., Liu, B., Yao, X., & Wang, X. (2021) · Age and Ageing · doi:10.1093/ageing/afab272 · Cited by 28
Sencan, C., Dost, F. S., Bulut, E. A., & Işık, A. T. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111832 · Cited by 27
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2974 · Cited by 22
Self-citationIda, S., Murata, K., Nakai, M., Ito, S., Malmstrom, T. K., Ishihara, Y., Imataka, K., Uchida, A., Monguchi, K., Kaneko, R., et al. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13461 · Cited by 23
Kouw, I. W. K., Gorissen, S. H. M., Burd, N. A., Cermak, N. M., Gijsen, A. P., van Kranenburg, J. M. X., & van Loon, L. J. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1234 · Cited by 28
Jo, M. H., Lim, T. S., Jeon, M. Y., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Han, K., & Kim, S. U. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030322 · Cited by 22
Self-citationOh, C., Park, J. H., Chung, H. S., Yu, J. M., Chung, W., Kang, J. G., & Moon, S. (2020) · Medicine · doi:10.1097/md.0000000000022036 · Cited by 20
Park, S., Kim, S., & Shin, J. Y. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13216 · Cited by 21
Self-citationExercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
Yang, X., Wang, L., Zhang, L., Zhai, X., Sheng, X., Quan, H., & Lin, H. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01130-w · Cited by 22
Worldwide burden of antidiabetic drug-induced sarcopenia: An international pharmacovigilance study
Kong, J., Park, S., Kim, T. H., Lee, J. E., Cho, H., Oh, J., Lee, S., Jo, H., Lee, H., Lee, K., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105656 · Cited by 23
Self-citationTanaka, K.-I., Kanazawa, I., Kaji, H., & Sugimoto, T. (2016) · Bone · doi:10.1016/j.bone.2016.11.007 · Cited by 21
Inoguchi, T., Fukuhara, S., Yamato, M., Nakai, M., Etoh, T., Masakado, M., Suehiro, S., Umeda, F., & Yamauchi, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43543-6 · Cited by 20
Bassil, M. S., Marliss, E. B., Morais, J. A., Pereira, S., Chevalier, S., & Gougeon, R. (2010) · Diabetologia · doi:10.1007/s00125-010-1980-9 · Cited by 22
Novel subgroups of obesity and their association with outcomes: a data-driven cluster analysis
Takeshita, S., Nishioka, Y., Tamaki, Y., Kamitani, F., Mohri, T., Nakajima, H., Kurematsu, Y., Okada, S., Myojin, T., Noda, T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-17648-1 · Cited by 19
Park, S., Cha, H.-N., Shin, M., Park, S., Kim, Y., Kim, M., Shin, K., Thoudam, T., Lee, E. J., Wolfe, R. R., et al. (2024) · Diabetes · doi:10.2337/db23-0432 · Cited by 19
Liu, J., Zhao, H., Zhao, L., Chen, Y., Zhang, L., Tao, B., Sun, L., Zhao, Y., Wang, W., Xu, M.-Y., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1112 · Cited by 21
The Effect of Type 2 Diabetes on Body Composition of Older Adults
Koster, A., & Schaap, L. S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.020 · Cited by 23
Decreased Muscle Strength and Quality in Diabetes-Related Dementia
Tsugawa, A., Ogawa, Y., Takenoshita, N., Kaneko, Y., Hatanaka, H., Jaime, E., Fukasawa, R., & Hanyu, H. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000485177 · Cited by 22
Effect of 10% dietary protein intake on whole body protein kinetics in type 2 diabetic adults
Labonte, C. C., Chevalier, S., Marliss, E. B., Morais, J. A., & Gougeon, R. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.12.022 · Cited by 19
“Such impairment may partly explain the accelerated decline in muscle mass, strength and functional capacity in T2Dwith aging [18,19].”
BackgroundAndersen, H. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00007-2 · Cited by 27
The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients
Öztürk, Z. A., Türkbeyler, İ. H., Demir, Z., Bilici, M., & Kepekçi, Y. (2017) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2018.1068 · Cited by 21
Age-Related Changes in Muscle and Bone
Pasco, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-25890-0_3 · Cited by 25
Bouchi, R., Sonoda, N., Itoh, J., Ono, Y., Fukuda, T., Takeuchi, T., Kishimoto, J., Yamada, T., & Ogawa, Y. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0599 · Cited by 22
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel
Chiodini, I., Gaudio, A., Palermo, A., Napoli, N., Vescini, F., Falchetti, A., Merlotti, D., Eller-Vainicher, C., Carnevale, V., Scillitani, A., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.04.014 · Cited by 20
Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
Jung, Y. S., Kim, N. H., Ryu, S., Park, J. H., Park, D. I., & Sohn, C. I. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000724 · Cited by 17
Self-citationHan, T., Yuan, T., Liang, X., Chen, N., Song, J., Zhao, X., Weng, Y., & Hu, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s360942 · Cited by 20
Verschueren, A., Palminha, C., Delmont, É., & Attarian, S. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.019 · Cited by 16
Yu, J., Loh, K., Yang, H.-Q., Du, M.-R., Wu, Y.-X., Liao, Z., Guo, A., Yang, Y., Chen, B., Zhao, Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03728-8 · Cited by 18
Wang, J., Zhou, C., Zhang, Q., & Liu, Z. (2023) · Amino Acids · doi:10.1007/s00726-023-03330-0 · Cited by 18
Appendicular muscle mass and exercise/sports participation history in young Japanese women
Ayabe, M., Kumahara, H., Yamaguchi-Watanabe, A., Chiba, H., Kobayashi, N., Sakuma, I., & Ishii, K. (2019) · Annals of Human Biology · doi:10.1080/03014460.2019.1641221 · Cited by 20
“…tissue, mainly caused by lower skeletal muscle mass, leads to functional impairments (Auyeung et al. 2014), osteoporosis (Walsh et al. 2006) and metabolic disorders, including hyperglycaemia, insulin resistance, hypercholesterolaemia and arteriosclerosis (Kim et al. 2010; Sanada et al. 2010, 2012).”
BackgroundGranados, A., Beach, E. A., Christiansen, A. J., Patterson, B. W., Wallendorf, M., & Arbeláez, A. M. (2021) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.06.004 · Cited by 18
Bell, K. E., Paris, M. T., Avrutin, E., & Mourtzakis, M. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12957 · Cited by 21
Enhancing health span: muscle stem cells and hormesis
Calabrese, E. J., & Calabrese, V. (2022) · Biogerontology · doi:10.1007/s10522-022-09949-y · Cited by 19
“Sarcopenia increases the risk of muscle damage (Faulkner et al. 1995), serious falls and injury (Tinetti 2001), obesity (Stenholm et al. 2008), and diabetes (Kim et al. 2010; Ghosh et al. 2015).”
BackgroundKubota, M., Matsuda, S., Matsuda, M., Yamamoto, K., & Yoshii, Y. (2022) · BMC Nephrology · doi:10.1186/s12882-022-03040-x · Cited by 20
Hsu, Y.-T., Lin, J.-Y., Lin, C., Lee, Y., & Chang, W. (2023) · Nutrients · doi:10.3390/nu15183892 · Cited by 19
“T2DM was independently associated with an increased risk of sarcopenia, suggesting that patients with T2DM should be considered in screening for sarcopenia [16].”
BackgroundCui, H., Hu, D., Liu, Y., & Zhao, J. (2023) · Gene · doi:10.1016/j.gene.2023.148053 · Cited by 18
Factors Contributing to Sarcopenia among Community-dwelling Older Korean Adults
Kim, H. H., Kim, J. S., & Yu, J. (2014) · Journal of Korean Gerontological Nursing · doi:10.17079/jkgn.2014.16.2.170 · Cited by 16
“또한 앞서 밝힌 바와 같이 근감소증은 다양한 요인들이 관련되어 있음에 도 불구하고 국내에서 수행된 근감소증 관련 연구들은 주로 개별 질환이나 걷기, 신체활동 등(Chin et al., 2013; Kim et al., 2010; Kim, Kim, & Hwang, 2013)과 같이 개별 관련요 인에 관한 연구가 대부분으로 다각적인 관련요인들을 고찰한 연구는 드물다.”
Sambashivaiah, S., Harridge, S. D. R., Sharma, N., Selvam, S., Rohatgi, P., & Kurpad, A. V. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00179 · Cited by 16
Chan, L., Yang, Y.-C., Lin, H.-C., Wahlqvist, M. L., Hung, Y., & Lee, M. (2021) · Nutrition · doi:10.1016/j.nut.2021.111269 · Cited by 17
Obesity-related metabolite profiles of black women spanning the epidemiologic transition
Dugas, L. R., Chorell, E., Plange‐Rhule, J., Lambert, E. V., Cao, G., Cooper, R., Layden, B. T., Scholten, D., Olsson, T., Luke, A. H., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-0960-6 · Cited by 18
Yoshida, N., Miyake, T., Yamamoto, S., Furukawa, S., Senba, H., Kanzaki, S., Koizumi, M., Ishihara, T., Yoshida, O., Hirooka, M., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0760-18 · Cited by 17
Tay, W. L. W., Quek, R. Y. C., Kaur, B., Lim, J., & Henry, C. J. (2022) · JMIR Public Health and Surveillance · doi:10.2196/33478 · Cited by 22
Paez, H. G., Ferrandi, P. J., Pitzer, C. R., Mohamed, J. S., & Alway, S. E. (2023) · The FASEB Journal · doi:10.1096/fj.202202029r · Cited by 15
Zeng, F., Huang, L., Zhang, Y., Hong, X., Weng, S., Shen, X., Zhao, F., & Yan, S. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2202511 · Cited by 17
“Sarcopenia is a syndrome characterized by the continuous loss of skeletal muscle mass, strength, and function [1], which is common in diabetic patients [2, 3] and has recently been identified as a chronic complication of diabetes [4].”
BackgroundInoue, T., Takeuchi, I., Iida, Y., Takahashi, K., Nagano, F., Miyazaki, S., Shirado, K., Yoshimura, Y., Momosaki, R., Maeda, K., et al. (2022) · JMA Journal · doi:10.31662/jmaj.2021-0202 · Cited by 15
“Diabetes, kidney disease, and liver disease Many patients with diabetes, kidney disease, and liver disease have nutritional disorders that lead to increased complications and mortality (85), (86), ((87)).”
BackgroundDiabetes and osteoporosis – Treating two entities: A challenge or cause for concern?
Rasmussen, N. H., & Vestergaard, P. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101779 · Cited by 19
Association between Appendicular Fat Mass and Metabolic Risk Factors
Park, S.-Y., Kwon, K. Y., Kim, J. H., Choi, H. H., Han, K. H., & Han, J. H. (2014) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2014.35.4.182 · Cited by 18
Metadata
- Authors
- Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M.
- Affiliations
- Korea University (KR)
- Sungshin Women's University (KR)
- Soonchunhyang University (KR)
- Seoul National University (KR)
- Corresponding author
- Choi, Kyung Mook
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-04-22
- Volume
- 33
- Issue
- 7
- Pages
- 1497-1499
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890348
- OpenAlex
- W2097531030
- Cited by
- 585
- References
- 12
- Citations by year
- 2026: 24 · 2025: 44 · 2024: 41 · 2023: 40 · 2022: 46 · 2021: 64 · 2020: 59 · 2019: 49 · 2018: 35 · 2017: 31 · 2016: 38 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 13
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Korea University
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenia, type 2 diabetes, prevalence, skeletal muscle index, body composition, risk factors, older adults, physical disability
- MeSH terms
- Adult, Aged, Aged, 80 and over, Body Composition, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Absorptiometry, Photon, Prevalence, Logistic Models, Muscle, Skeletal, Asian People, Young Adult, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
